London based health tech startup secures $11m investment
A UK and US health tech startup has announced that it has secured $11m of funding.
Quit Genius, which has its UK headquarters in London, has received the investment from a Series A funding round led by Octopus Ventures.
Hubert Burda Media’s international growth capital arm BurdaPrincipal Investments joined the round along with Y Combinator, Startup Health, and Triple Point Ventures.
The company uses cognitive behavioural therapy aims to aid users in quitting smoking and vaping tobacco products.
Quit Genius is expected to use the funding to expand into other types of addiction, including alcohol and opioid addiction.
Amelia Townsend, principal at BurdaPrincipal Investments, commented: “At BPI we are working in-depth into the health tech space.
“We are delighted to join the Quit Genius team and our fellow investors and are looking forward to being part of the journey!”
Want your business, product or service to be seen regionally and nationally? Bdaily helps you get your story in front of the right audience, every day. Find out how Bdaily can help →
Join more than 55,000 subscribers by signing up to our daily bulletin each morning here.
Enjoy the read? Get Bdaily delivered.
Sign up to receive our popular morning London email for free.
The real value of AI is the time it gives back
Breaking the magnetic pull of London
AI scepticism is healthy. Inaction isn't.
What does NPPF mean for site price and planning gain?
What new NPPF rules mean for landowners
The hidden cost squeezing Britain's economy
Teesside deserves more than cashback devolution
Construction must be built on commercial discipline
Devolution needs financial firepower to drive growth
The value of creating a stronger careers route
Apprenticeships: Invest in talent or keep chasing it
Are you ready for salary transparency?